All Stories

  1. Global burden of 292 causes of death in 204 countries and territories and 660 subnational locations, 1990–2023: a systematic analysis for the Global Burden of Disease Study 2023
  2. Global age-sex-specific all-cause mortality and life expectancy estimates for 204 countries and territories and 660 subnational locations, 1950–2023: a demographic analysis for the Global Burden of Disease Study 2023
  3. Vitamin D and Postoperative Recovery in Elderly Ribeirinhos—Riverside Amazon Communities with Femur Fractures
  4. Predictive modeling of depression and anxiety after myocardial infarction: a study on influential factors and heart rate variability
  5. Global, Regional, and National Burden of Nontraumatic Subarachnoid Hemorrhage
  6. Global, regional, and national prevalence of kidney failure with replacement therapy and associated aetiologies, 1990–2023: a systematic analysis for the Global Burden of Disease Study 2023
  7. Photobiomodulation Therapy Reduces Oxidative Stress and Inflammation to Alleviate the Cardiotoxic Effects of Doxorubicin in Human Stem Cell-Derived Ventricular Cardiomyocytes
  8. Prevalence of Vision Loss in Latin America and the Caribbean in 2020: Magnitude and Temporal Trends
  9. Designing Personalized Multimodal Mnemonics With AI: A Medical Student’s Implementation Tutorial
  10. Characterising acute and chronic care needs: insights from the Global Burden of Disease Study 2019
  11. Human Pinealectomy Syndrome and the Impact of Melatonin Replacement Therapy: 1‐Cardiovascular Function
  12. Circadian system coordination: new perspectives beyond classical models
  13. Correction: Comparison between melatonin versus melatonin and photobiomodulation versus photobiomodulation in the treatment of Alopecia X in German Spitz dogs: Clinical, randomized, double-blind, parallel, non-inferiority protocol
  14. Global, regional, and national prevalence of child and adolescent overweight and obesity, 1990–2021, with forecasts to 2050: a forecasting study for the Global Burden of Disease Study 2021
  15. Global, regional, and national prevalence of adult overweight and obesity, 1990–2021, with forecasts to 2050: a forecasting study for the Global Burden of Disease Study 2021
  16. Global, regional, and national progress towards the 2030 global nutrition targets and forecasts to 2050: a systematic analysis for the Global Burden of Disease Study 2021
  17. Comparing and assessing physical activity and sedentary behaviour guidelines for different populations with and without chronic conditions and/or disabilities: a systematic review protocol
  18. High-frequency chest wall oscillation devices: An umbrella review and bibliometric analysis
  19. Global, regional, and national burden of stroke and its risk factors, 1990–2021: a systematic analysis for the Global Burden of Disease Study 2021
  20. Global, regional, and national burden of pulmonary arterial hypertension, 1990–2021: a systematic analysis for the Global Burden of Disease Study 2021
  21. From science to society: Exploring the nexus between obesity research and public awareness in Brazil
  22. Global estimates on the number of people blind or visually impaired by Uncorrected Refractive Error: a meta-analysis from 2000 to 2020
  23. Comparison between melatonin versus melatonin and photobiomodulation versus photobiomodulation in the treatment of Alopecia X in German Spitz dogs: Clinical, randomized, double-blind, parallel, non-inferiority protocol
  24. The burden of neurological conditions in north Africa and the Middle East, 1990–2019: a systematic analysis of the Global Burden of Disease Study 2019
  25. Global burden of 288 causes of death and life expectancy decomposition in 204 countries and territories and 811 subnational locations, 1990–2021: a systematic analysis for the Global Burden of Disease Study 2021
  26. Burden of disease scenarios for 204 countries
  27. Global burden and strength of evidence for 88 risk factors in 204 countries and 811 subnational locations, 1990–2021: a systematic analysis for the Global Burden of Disease Study 2021
  28. Global estimates on the number of people blind or visually impaired by glaucoma: A meta-analysis from 2000 to 2020
  29. Global Health Trends 1950–2021: Impact of COVID-19 on Mortality and Population Growth
  30. Global, regional, and national burden of disorders affecting the nervous system, 1990–2021: a systematic analysis for the Global Burden of Disease Study 2021
  31. Global fertility in 204 countries and territories, 1950–2021, with forecasts to 2100: a comprehensive demographic analysis for the Global Burden of Disease Study 2021
  32. Evidence for the druggability of aldosterone targets in heart failure: A bioinformatics and data science-driven decision-making approach
  33. High and low pitch sound stimuli effects on heart-brain coupling
  34. Global Burden of Cardiovascular Diseases and Risks, 1990-2022
  35. High and Low Pitch Sound Stimuli Effects on Heart-Brain Coupling
  36. Global burden of peripheral artery disease and its risk factors, 1990–2019: a systematic analysis for the Global Burden of Disease Study 2019
  37. Global, regional, and national burden of diabetes from 1990 to 2021, with projections of prevalence to 2050: a systematic analysis for the Global Burden of Disease Study 2021
  38. Determinants of cervical spine disorders in military pilots: a systematic review
  39. The burden of metabolic risk factors in North Africa and the Middle East, 1990–2019: findings from the Global Burden of Disease Study
  40. Effect of air pollution on disease burden, mortality, and life expectancy in North Africa and the Middle East: a systematic analysis for the Global Burden of Disease Study 2019
  41. Global burden of chronic respiratory diseases and risk factors, 1990–2019: an update from the Global Burden of Disease Study 2019
  42. Sexual Dimorphism in the Expression of Cardiac and Hippocampal Renin-Angiotensin and Kallikrein–Kinin Systems in Offspring from Mice Exposed to Alcohol during Gestation
  43. Multiplatform-Integrated Identification of Melatonin Targets for a Triad of Psychosocial-Sleep/Circadian-Cardiometabolic Disorders
  44. Quantitative cardiac autonomic outcomes of hydrotherapy in women during the first stage of labor
  45. Editorial: Methods and applications in integrative physiology
  46. “Involve Me and I Learn”: Active Learning in a Hybrid Medical Biochemistry First Year Course on an American-Style MD Program in the UAE
  47. Burnout and Cardiovascular Risk in Healthcare Professionals During the COVID-19 Pandemic
  48. Photobiomodulation therapy's effects on cardiac fibrosis activation after experimental myocardial infarction
  49. Urinary Angiotensinogen-Melatonin Ratio in Gestational Diabetes and Preeclampsia
  50. Diabetes mortality and trends before 25 years of age: an analysis of the Global Burden of Disease Study 2019
  51. Heart Rate Variability Indices as Possible Biomarkers for the Severity of Post-traumatic Stress Disorder Following Pregnancy Loss
  52. The validation of oxygen uptake efficiency slope in patients with stroke
  53. Using the Gensini score to estimate severity of STEMI, NSTEMI, unstable angina, and anginal syndrome
  54. Global, regional, and national burden of stroke and its risk factors, 1990–2019: a systematic analysis for the Global Burden of Disease Study 2019
  55. Physicians’ Attitudes Toward Telemedicine Consultations During the COVID-19 Pandemic: Cross-sectional Study
  56. Cross-Cultural Adaptation, Reliability, and Validity of a Brazilian of Short Version of the Posttraumatic Diagnostic Scale
  57. Health and Well-Being of Athletes During the Coronavirus Pandemic: A Scoping Review
  58. Bang the gavel: animal experimentation on trial—an interdisciplinary mock trial at the school of health sciences
  59. Prevalence and Determinants of Immediate and Long-Term PTSD Consequences of Coronavirus-Related (CoV-1 and CoV-2) Pandemics among Healthcare Professionals: A Systematic Review and Meta-Analysis
  60. The action of aripiprazole and brexpiprazole at the receptor level in singultus
  61. Impact of COVID-19 Pandemic Burnout on Cardiovascular Risk in Healthcare Professionals Study Protocol: A Multicenter Exploratory Longitudinal Study
  62. The value of coronary computed tomography angiography in assessing the cardiac circulation of an outpatient-based population
  63. The efficacy of baroreflex activation therapy for heart failure
  64. Cardiovascular and Quality of Life Outcomes of a 3-Month Physical Exercise Program in Two Brazilian Communities
  65. Next-generation sequencing identifies a novel heterozygous I229T mutation on LMNA associated with familial cardiac conduction disease
  66. Cardiovascular and Quality of Life Outcomes of a 3-Month Physical Exercise Program in Two Brazilian Communities
  67. Melatonin Therapy Improves Cardiac Autonomic Modulation in Pinealectomized Patients
  68. Therapeutic Renin Inhibition in Diabetic Nephropathy—A Review of the Physiological Evidence
  69. What is the optimal duration of the TILT after administration of 0.4 mg nitroglycerin spray?
  70. Cardioprotective Melatonin: Translating from Proof-of-Concept Studies to Therapeutic Use
  71. Clinical outcomes of discordant exercise electrocardiographic and echocardiographic findings compared with concordant findings in patients with chest pain and no history of coronary artery disease
  72. Physical Activity Levels in a Structured Physical Exercise Community Program in Elderly
  73. Association between gene variants and the recurrence of atrial fibrillation
  74. Integrative bioinformatics analysis of miRNA and mRNA expression profiles and identification of associated miRNA-mRNA network in aortic dissection
  75. The Syntaxin-1A gene single nucleotide polymorphism rs4717806 associates with the risk of ischemic heart disease
  76. Obesity and metabolic syndrome in children in Brazil
  77. Identification of insulin-regulated aminopeptidase (IRAP) in the rat pineal gland and the modulation of melatonin synthesis by angiotensin IV
  78. Intrapartum Fetal Heart Rate: A Possible Predictor of Neonatal Acidemia and APGAR Score
  79. Melatonin, mitochondria and hypertension
  80. Association between Carotid Intima Media Thickness and Heart Rate Variability in Adults at Increased Cardiovascular Risk
  81. Quantifying Effects of Pharmacological Blockers of Cardiac Autonomous Control Using Variability Parameters
  82. Angiotensin—Encyclopedia of Stress
  83. Hormonal Physiology of Childbearing, an Essential Framework for Maternal–Newborn Nursing
  84. ICU Blood Pressure Variability May Predict Nadir of Respiratory Depression After Coronary Artery Bypass Surgery
  85. Morlet wavelet transforms of heart rate variability for autonomic nervous system activity
  86. Successful Pregnancy Following Assisted Reproduction in Woman With Systemic Lupus Erythematosus and Hypertension
  87. Cardiac autonomic dysfunction in elderly women with myocardial infarction
  88. PP.LB01.19
  89. Development of a monitoring system for evaluation of the mental health program in the city of Santarém, State of Pará, Brazil
  90. Sex-dependent differences in renal angiotensinogen as an early marker of diabetic nephropathy
  91. Heart Rate Detrended Fluctuation Indexes as Estimate of Obstructive Sleep Apnea Severity
  92. Avosentan is protective in hypertensive nephropathy at doses not causing fluid retention
  93. The Angiotensin-Melatonin Axis
  94. Brain RAS: Hypertension and Beyond
  95. Cardiovascular responses evoked by activation or blockade of GABAA receptors in the hypothalamic PVN are attenuated in transgenic rats with low brain angiotensinogen
  96. Differential diagnosis between experimental endophthalmitis and uveitis in vitreous with Raman spectroscopy and principal components analysis
  97. Brain Renin–Angiotensin System in Hypertension, Cardiac Hypertrophy, and Heart Failure
  98. Models of Hypertension and Blood Pressure Recording
  99. Antidiuretic Effects of the Endothelin Receptor Antagonist Avosentan
  100. Effect of SPP 635, a renin inhibitor, on intraocular pressure in glaucomatous monkey eyes
  101. Local renin–angiotensin system and the brain—A continuous quest for knowledge
  102. Effect of SPP 301, an Endothelin Antagonist, on Intraocular Pressure in Glaucomatous Monkey Eyes
  103. Nigral and striatal regulation of angiotensin receptor expression by dopamine and angiotensin in rodents: implications for progression of Parkinson’s disease
  104. Transgenic Angiotensin-Converting Enzyme 2 Overexpression in Vessels of SHRSP Rats Reduces Blood Pressure and Improves Endothelial Function
  105. Increased susceptibility to endotoxic shock in transgenic rats with endothelial overexpression of kinin B1 receptors
  106. Baroreflex control of heart rate and renal sympathetic nerve activity in rats with low brain angiotensinogen
  107. Antidiuretic effects of endothelin B receptor antagonism
  108. Mice deficient for both kinin receptors are normotensive and protected from endotoxin-induced hypotension
  109. Angiotensin*
  110. Angiotensin1
  111. Enhanced isoproterenol-induced cardiac hypertrophy in transgenic rats with low brain angiotensinogen
  112. Brain renin-angiotensin system
  113. Altered circadian rhythm reentrainment to light phase shifts in rats with low levels of brain angiotensinogen
  114. Role of the renal nerves in blood pressure in male and female SHR
  115. Altered renal response to acute volume expansion in transgenic rats harboring the human tissue kallikrein gene
  116. Genetic targeting of the brain renin-angiotensin system in transgenic rats: Impact on stress-induced renin release
  117. Differential regulation of central vasopressin receptors in transgenic rats with low brain angiotensinogen
  118. Expression of an angiotensin-(1–7)-producing fusion protein produces cardioprotective effects in rats
  119. CIRCADIAN REGULATION OF ANGIOTENSINOGEN IN KIDNEY - EFFECT OF ANGIOTENSIN II
  120. Androgen receptor independent cardiovascular action of the antiandrogen flutamide
  121. Expression of smooth muscle MyHC B in blood vessels of hypertrophied heart in experimentally hypertensive rats
  122. Brain Renin-Angiotensin System
  123. Abolition of End-Organ Damage by Antiandrogen Treatment in Female Hypertensive Transgenic Rats
  124. Abolition of Hypertension-Induced End-Organ Damage by Androgen Receptor Blockade in Transgenic Rats Harboring the Mouse Ren-2 Gene
  125. Differential effects of angiotensin II and angiotensin-(1-7) at the nucleus tractus solitarii of transgenic rats with low brain angiotensinogen
  126. Locally synthesized angiotensin modulates pineal melatonin generation
  127. Tissue renin-angiotensin systems: new insights from experimental animal models in hypertension research
  128. Alterations in Blood Pressure and Heart Rate Variability in Transgenic Rats With Low Brain Angiotensinogen
  129. Alterations of the renin-angiotensin system at the RVLM of transgenic rats with low brain angiotensinogen
  130. Reduced cardiac hypertrophy and altered blood pressure control in transgenic rats with the human tissue kallikrein gene
  131. ALTERED CARDIOVASCULAR FUNCTIONALITY OF THE RENIN-ANGIOTENSIN SYSTEM AT THE ROSTRAL VENTROLATERAL MEDULLA OF TRANSGENIC RATS WITH LOW BRAIN ANGIOTENSINOGEN
  132. Angiotensin peptides acting at rostral ventrolateral medulla contribute to hypertension of TGR(mREN2)27 rats
  133. The Brain Renin-Angiotensin System Modulates Angiotensin II-Induced Hypertension and Cardiac Hypertrophy
  134. Blood pressure reduction and diabetes insipidus in transgenic rats deficient in brain angiotensinogen
  135. Functional evidence for alternative ANG II-forming pathways in hamster cardiovascular system
  136. Local renin–angiotensin system in the pineal gland
  137. High levels of human chymase expression in the pineal and pituitary glands
  138. Mechanismus der Gewebe-Angiotensin-II-Bildung im Herzen und neue Befunde zum kardialen Angiotensin-II-System
  139. Effects of α-trinositol administered extra- and intracellularly (using liposomes) on rat aorta rings
  140. Multiple effects of tyrosine kinase inhibitors on vascular smooth muscle contraction
  141. Effects of liposome-entrapped platelet-activating factor in the isolated rat trachea